Skip to main content
. Author manuscript; available in PMC: 2024 Aug 15.
Published in final edited form as: Expert Rev Anti Infect Ther. 2023 Aug 15;21(9):929–941. doi: 10.1080/14787210.2023.2247161

Table 1:

Epidemiologic subtypes of Kaposi sarcoma and their disease manifestations

Disease Manifestations Populations Impacted
Classic KS Lesions on the skin and specifically occur in distal extremities.
Rarer occurrence in mucus membranes, viscera or lymph nodes.
Middle aged to older men; Mediterranean or Central/Eastern European ancestry
Cisgender men more commonly affected
Endemic KS Nodular lesions typically affecting the lower extremities that can be aggressive.
Lymphedema is common.
Individuals from sub-Saharan Africa
Impacts adults and children
HIV-associated KS Cutaneous involvement may occur over lower extremities, but can affect other parts of the body Visceral involvement, lesions may appear raised, discolored and/or ulcerated:
 • Oral – hard and soft palate
 • GI - lesions can be asymptomatic or present as nausea/vomiting, bleeding, weight loss
 • Pulmonary - dyspnea, cough, or hemoptysis.
Lymphedema is common
Persons living with HIV.
Severity of disease may be related to underlying immunosuppression, with lower CD4 count associated with more sever disease.
Iatrogenic/Transplant- associated KS Lesions are often localized to the skin with visceral organ involvement less commonly involved Solid organ and hematopoietic stem cell transplant recipients
HIV-negative (non-epidemic KS) Lesions limited to the skin that are localized
Less associated with lymphedema
Younger, non-immunocompromised MSM